196 related articles for article (PubMed ID: 25051297)
1. Endogenous cortisol levels influence exposure therapy in spider phobia.
Lass-Hennemann J; Michael T
Behav Res Ther; 2014 Sep; 60():39-45. PubMed ID: 25051297
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids enhance in vivo exposure-based therapy of spider phobia.
Soravia LM; Heinrichs M; Winzeler L; Fisler M; Schmitt W; Horn H; Dierks T; Strik W; Hofmann SG; de Quervain DJ
Depress Anxiety; 2014 May; 31(5):429-35. PubMed ID: 24265104
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure cortisol administration does not augment the success of exposure therapy: A randomized placebo-controlled study.
Raeder F; Merz CJ; Tegenthoff M; Wolf OT; Margraf J; Zlomuzica A
Psychoneuroendocrinology; 2019 Jan; 99():174-182. PubMed ID: 30245330
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids reduce phobic fear in humans.
Soravia LM; Heinrichs M; Aerni A; Maroni C; Schelling G; Ehlert U; Roozendaal B; de Quervain DJ
Proc Natl Acad Sci U S A; 2006 Apr; 103(14):5585-90. PubMed ID: 16567641
[TBL] [Abstract][Full Text] [Related]
5. Brain-based mediation of non-conscious reduction of phobic avoidance in young women during functional MRI: a randomised controlled experiment.
Siegel P; Wang Z; Murray L; Campos J; Sims V; Leighton E; Peterson BS
Lancet Psychiatry; 2020 Nov; 7(11):971-981. PubMed ID: 33069319
[TBL] [Abstract][Full Text] [Related]
6. The relative contributions of fear and disgust reductions to improvements in spider phobia following exposure-based treatment.
Olatunji BO; Huijding J; de Jong PJ; Smits JA
J Behav Ther Exp Psychiatry; 2011 Mar; 42(1):117-21. PubMed ID: 20732677
[TBL] [Abstract][Full Text] [Related]
7. Delaying in vivo exposure to a tarantula with very brief exposure to phobic stimuli.
Siegel P; Gallagher KA
J Behav Ther Exp Psychiatry; 2015 Mar; 46():182-8. PubMed ID: 25460265
[TBL] [Abstract][Full Text] [Related]
8. One-session computer-based exposure treatment for spider-fearful individuals--efficacy of a minimal self-help intervention in a randomised controlled trial.
Müller BH; Kull S; Wilhelm FH; Michael T
J Behav Ther Exp Psychiatry; 2011 Jun; 42(2):179-84. PubMed ID: 21315879
[TBL] [Abstract][Full Text] [Related]
9. Contamination-Focused Exposure as a Treatment for Disgust-Based Fears: A Preliminary Test in Spider-Fearful Women.
Cougle JR; Summers BJ; Harvey AM; Dillon KH; Allan NP
Behav Cogn Psychother; 2016 Nov; 44(6):640-651. PubMed ID: 27465309
[TBL] [Abstract][Full Text] [Related]
10. Immersive 3D exposure-based treatment for spider fear: A randomized controlled trial.
Minns S; Levihn-Coon A; Carl E; Smits JAJ; Miller W; Howard D; Papini S; Quiroz S; Lee-Furman E; Telch M; Carlbring P; Xanthopoulos D; Powers MB
J Anxiety Disord; 2018 Aug; 58():1-7. PubMed ID: 29909286
[TBL] [Abstract][Full Text] [Related]
11. The association between estradiol levels, hormonal contraceptive use, and responsiveness to one-session-treatment for spider phobia in women.
Graham BM; Li SH; Black MJ; Öst LG
Psychoneuroendocrinology; 2018 Apr; 90():134-140. PubMed ID: 29482136
[TBL] [Abstract][Full Text] [Related]
12. Positive valence reduces susceptibility to return of fear and enhances approach behavior.
Dour HJ; Brown LA; Craske MG
J Behav Ther Exp Psychiatry; 2016 Mar; 50():277-82. PubMed ID: 26497447
[TBL] [Abstract][Full Text] [Related]
13. Generalization of Extinguished Fear to Untreated Fear Stimuli after Exposure.
Preusser F; Margraf J; Zlomuzica A
Neuropsychopharmacology; 2017 Dec; 42(13):2545-2552. PubMed ID: 28589965
[TBL] [Abstract][Full Text] [Related]
14. Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement.
Steudte-Schmiedgen S; Fay E; Capitao L; Kirschbaum C; Reinecke A
J Psychopharmacol; 2021 Jun; 35(6):641-651. PubMed ID: 33908295
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled clinical trial of in virtuo and in vivo exposure for spider phobia.
Michaliszyn D; Marchand A; Bouchard S; Martel MO; Poirier-Bisson J
Cyberpsychol Behav Soc Netw; 2010 Dec; 13(6):689-95. PubMed ID: 21142994
[TBL] [Abstract][Full Text] [Related]
16. What you cannot see can help you: the effect of exposure to unreportable stimuli on approach behavior.
Weinberger J; Siegel P; Siefert C; Drwal J
Conscious Cogn; 2011 Jun; 20(2):173-80. PubMed ID: 21300558
[TBL] [Abstract][Full Text] [Related]
17. Pathways to change in one-session exposure with and without cognitive intervention: an exploratory study in spider phobia.
Raes AK; Koster EH; Loeys T; De Raedt R
J Anxiety Disord; 2011 Oct; 25(7):964-71. PubMed ID: 21741797
[TBL] [Abstract][Full Text] [Related]
18. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid Administration Improves Aberrant Fear-Processing Networks in Spider Phobia.
Nakataki M; Soravia LM; Schwab S; Horn H; Dierks T; Strik W; Wiest R; Heinrichs M; de Quervain DJ; Federspiel A; Morishima Y
Neuropsychopharmacology; 2017 Jan; 42(2):485-494. PubMed ID: 27644128
[TBL] [Abstract][Full Text] [Related]
20. Exposure treatment in multiple contexts attenuates return of fear via renewal in high spider fearful individuals.
Bandarian-Balooch S; Neumann DL; Boschen MJ
J Behav Ther Exp Psychiatry; 2015 Jun; 47():138-44. PubMed ID: 25601294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
